Medical Device | April 28, 2026
Stryker launches Trident II Hip System in India
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof
Ajax's lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with first proof-of-concept clinical data to be presented later in 2026
The results signal shift beyond paclitaxel-coated balloon (PCB) angioplasty in femoropopliteal artery disease
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
_256_384.png)
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
Rs. 40 cr buyback, 200% dividend announced
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
Subscribe To Our Newsletter & Stay Updated
